The company is to release its Q4 report on the earnings day on February 23, 2023. Vanguard Group has increased its stake in the company by 3.60%. Dynavax Technologies Corp. is a biopharmaceutical c...
Tag: DVAX
I’m Going to Give This Biotech Another Shot
Dynavax Technologies (DVAX) has spent 2022 building up its cash balance as the biotech raked in revenues from its adjuvant that’s used by several Covid vaccine makers, primarily in Europe. In ad...